758 related articles for article (PubMed ID: 32477328)
21. Haploidentical transplantation in pediatric non-malignant diseases: A retrospective analysis on behalf of the Spanish Group for Hematopoietic Transplantation (GETH).
Torres Canizales J; Ferreras C; Pascual A; Alonso L; Regueiro A; Plaza M; Pérez Hurtado JM; Benito A; Couselo JM; Fuster JL; Díaz-Almirón M; Bueno D; Mozo Y; Gómez López A; Vicario JL; Balas A; Sisinni L; Díaz de Heredia C; Pérez-Martínez A
Eur J Haematol; 2021 Feb; 106(2):196-204. PubMed ID: 33084101
[TBL] [Abstract][Full Text] [Related]
22. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients.
Arnold DE; MacMath D; Seif AE; Heimall JR; Wang Y; Monos D; Grupp SA; Bunin NJ
Transplant Cell Ther; 2021 Feb; 27(2):169.e1-169.e9. PubMed ID: 33830028
[TBL] [Abstract][Full Text] [Related]
23. Treosulfan-Based Conditioning Regimen in Haematopoietic Stem Cell Transplantation with TCRαβ/CD19 Depletion in Nijmegen Breakage Syndrome.
Laberko A; Sultanova E; Gutovskaya E; Radygina S; Deripapa E; Kantulaeva A; Trakhtman P; Brilliantova V; Starichkova J; Shcherbina A; Maschan M; Maschan A; Balashov D
J Clin Immunol; 2020 Aug; 40(6):861-871. PubMed ID: 32602054
[TBL] [Abstract][Full Text] [Related]
24. Control of graft-versus-host disease with rabbit anti-thymocyte globulin, rituximab, and bortezomib in TCRαβ/CD19-depleted graft transplantation for leukemia in children: a single-center retrospective analysis of two GVHD-prophylaxis regimens.
Shekhovtsova Z; Shelikhova L; Balashov D; Zakharova V; Ilushina M; Voronin K; Kurnikova E; Muzalevskii Y; Kazachenok A; Pershin D; Novichkova G; Maschan A; Maschan M
Pediatr Transplant; 2020 Feb; 24(1):e13594. PubMed ID: 31680369
[TBL] [Abstract][Full Text] [Related]
25. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
[TBL] [Abstract][Full Text] [Related]
26. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
[TBL] [Abstract][Full Text] [Related]
27. Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.
Gorin NC; Labopin M; Blaise D; de Groot M; Socié G; Bourhis JH; Ciceri F; Polge E; Nagler A; Mohty M
Cancer; 2020 Mar; 126(5):1004-1015. PubMed ID: 31774557
[TBL] [Abstract][Full Text] [Related]
28. Alternative donor: αß/CD19 T-cell-depleted haploidentical hematopoietic stem cell transplantation for sickle cell disease.
Foell J; Kleinschmidt K; Jakob M; Troeger A; Corbacioglu S
Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):98-105. PubMed ID: 32202248
[TBL] [Abstract][Full Text] [Related]
29. Post-Transplantation Immunosuppression After TCRΑβ/CD19 Graft Depletion Does Not Improve HSCT Outcomes in Primary Immunodeficiency.
Laberko A; Idarmacheva A; Glushkova S; Pershin D; Shelikhova L; Maschan M; Maschan A; Balashov D
Transplant Cell Ther; 2022 Mar; 28(3):172.e1-172.e4. PubMed ID: 34875404
[TBL] [Abstract][Full Text] [Related]
30. Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation.
Kim DH; Shin DY; Koh Y; Kim I; Yoon SS; Byun JM; Hong J
Sci Rep; 2024 Jun; 14(1):13885. PubMed ID: 38880835
[TBL] [Abstract][Full Text] [Related]
31. Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients.
Lang P; Feuchtinger T; Teltschik HM; Schwinger W; Schlegel P; Pfeiffer M; Schumm M; Lang AM; Lang B; Schwarze CP; Ebinger M; Urban C; Handgretinger R
Bone Marrow Transplant; 2015 Jun; 50 Suppl 2():S6-10. PubMed ID: 26039210
[TBL] [Abstract][Full Text] [Related]
32. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
33. TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders.
Merli P; Pagliara D; Galaverna F; Li Pira G; Andreani M; Leone G; Amodio D; Pinto RM; Bertaina A; Bertaina V; Mastronuzzi A; Strocchio L; Boccieri E; Pende D; Falco M; Di Nardo M; Del Bufalo F; Algeri M; Locatelli F
Blood Adv; 2022 Jan; 6(1):281-292. PubMed ID: 34592755
[TBL] [Abstract][Full Text] [Related]
34. Use of TCR α
Brettig T; Smart J; Choo S; Mechinaud F; Mitchell R; Raj TS; Cole T
J Clin Immunol; 2019 Jul; 39(5):505-511. PubMed ID: 31172381
[TBL] [Abstract][Full Text] [Related]
35. Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective.
Sharma A; Rastogi N; Chatterjee G; Kapoor R; Nivargi S; Yadav SP
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1033-e1036. PubMed ID: 33306606
[TBL] [Abstract][Full Text] [Related]
36. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
[TBL] [Abstract][Full Text] [Related]
37. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
[TBL] [Abstract][Full Text] [Related]
38. αβ
Dadi G; Jacoby E; Adam E; Hutt D; Varda-Bloom N; Bielorai B; Toren A
Pediatr Transplant; 2023 Aug; 27(5):e14531. PubMed ID: 37127942
[TBL] [Abstract][Full Text] [Related]
39. Haploidentical hematopoietic stem cell transplantation with αβTCR+/CD19+ depletion in pediatric patients with malignant and non-malignant disorders.
Bielorai B; Jacoby E; Varda-Bloom N; Hutt D; Churi C; Vernitsky H; Toren A
Bone Marrow Transplant; 2019 Aug; 54(Suppl 2):694-697. PubMed ID: 31431715
[TBL] [Abstract][Full Text] [Related]
40. Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trial.
Chang YJ; Wang Y; Mo XD; Zhang XH; Xu LP; Yan CH; Chen H; Chen YH; Chen Y; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
Cancer; 2017 Aug; 123(15):2881-2892. PubMed ID: 28301690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
